Elanco has announced a breakthrough targeted single-dose monoclonal antibody treatment for the deadly canine parvovirus in the US.
Pet Industry News is Australia and New Zealand’s leading news service for the pet industry.
Elanco has announced a breakthrough targeted single-dose monoclonal antibody treatment for the deadly canine parvovirus in the US.